The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $120.74

Today's change-0.42 -0.35%
Updated February 21 10:29 AM EST. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $120.74

Today's change-0.42 -0.35%
Updated February 21 10:29 AM EST. Delayed by at least 15 minutes.

Reversal following new 20-day high

Celgene Corp is lower today, dropping (U.S.)$0.42 or 0.35% to (U.S.)$120.74 after setting a new 20-day high. Over the last five days, shares have gained 3.18% and are currently 4.93% off of the 52-week high. Shares have underperformed the S&P 500 by 5.62% during the last year.

Key company metrics

  • Open(U.S.) $121.39
  • Previous close(U.S.) $121.16
  • High(U.S.) $122.22
  • Low(U.S.) $120.72
  • Bid / Ask(U.S.) $120.72 / (U.S.) $120.77
  • YTD % change+4.31%
  • Volume1,110,747
  • Average volume (10-day)3,529,059
  • Average volume (1-month)4,421,751
  • Average volume (3-month)4,672,307
  • 52-week range(U.S.) $94.39 to (U.S.) $127.00
  • Beta1.78
  • Trailing P/E48.56×
  • P/E 1 year forward16.78×
  • Forward PEG0.75×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.49
Updated February 21 10:29 AM EST. Delayed by at least 15 minutes.
S&P TSX0.59%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,9812,9832,7542,512
Total other revenue--------
Total revenue2,9812,9832,7542,512
Gross profit2,8672,8752,6432,406
Total cost of revenue114108111106
Total operating expense2,3522,6171,9631,488
Selling / general / administrative685698732543
Research & development1,1351,654949733
Depreciation / amortization1058717592
Interest expense (income), net operating--------
Unusual expense (income)31471-414
Other operating expenses, total--------
Operating income6283667921,024
Interest income (expense), net non-operating-136-137-136-135
Gain (loss) on sale of assets--------
Other--------
Income before tax499257695922
Income after tax429171598801
Income tax, total708597121
Net income429171598801
Total adjustments to net income--------
Net income before extra. items429171598801
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items429171598801
Inc. avail. to common incl. extra. items429171598801
Diluted net income429171598801
Dilution adjustment--------
Diluted weighted average shares802802802808
Diluted EPS excluding extraordinary itemsvalue per share0.530.210.750.99
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.870.270.741.01